Training activity information
Details
Select the appropriate monitoring methods for patients treated with novel and emerging therapies which may interfere with standard assays
Type
Developmental training activity (DTA)
Evidence requirements
Evidence the activity has been undertaken by the trainee​.
Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.
An action plan to implement learning and/or to address skills or knowledge gaps identified.
Considerations
- Interferences caused by monoclonal antibodies for the following assays:
- Flow cytometry
- Blood grouping and antibody investigation
- Implications for clinical interpretation
- Identification of alternative testing strategies
Relevant learning outcomes
| # | Outcome |
|---|---|
| # 2 |
Outcome
Apply laboratory techniques to support the use of stem cells in the treatment of haematological conditions. |
| # 3 |
Outcome
Appraise the application of novel and evolving therapies in the treatment of haematological conditions. |